FI955524A - Kiinteinä liuoksina olevia valmisteita - Google Patents

Kiinteinä liuoksina olevia valmisteita Download PDF

Info

Publication number
FI955524A
FI955524A FI955524A FI955524A FI955524A FI 955524 A FI955524 A FI 955524A FI 955524 A FI955524 A FI 955524A FI 955524 A FI955524 A FI 955524A FI 955524 A FI955524 A FI 955524A
Authority
FI
Finland
Prior art keywords
pct
solid solutions
date nov
preparations
sec
Prior art date
Application number
FI955524A
Other languages
English (en)
Swedish (sv)
Other versions
FI955524A0 (fi
Inventor
Sven Grabowski
Winfried Mueller
Joerg Rosenberg
Rudolf Binder
Axel Sanner
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI955524A0 publication Critical patent/FI955524A0/fi
Publication of FI955524A publication Critical patent/FI955524A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cephalosporin Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI955524A 1993-05-18 1995-11-16 Kiinteinä liuoksina olevia valmisteita FI955524A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4316537A DE4316537A1 (de) 1993-05-18 1993-05-18 Zubereitungen in Form fester Lösungen
PCT/EP1994/001489 WO1994026267A1 (de) 1993-05-18 1994-05-09 Zubereitungen in form fester lösungen

Publications (2)

Publication Number Publication Date
FI955524A0 FI955524A0 (fi) 1995-11-16
FI955524A true FI955524A (fi) 1995-11-16

Family

ID=6488330

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955524A FI955524A (fi) 1993-05-18 1995-11-16 Kiinteinä liuoksina olevia valmisteita

Country Status (23)

Country Link
US (1) US5684040A (fi)
EP (1) EP0697867B1 (fi)
JP (1) JPH08510219A (fi)
KR (1) KR960702305A (fi)
CN (1) CN1123524A (fi)
AT (1) ATE209913T1 (fi)
AU (1) AU688328B2 (fi)
BR (1) BR9406414A (fi)
CA (1) CA2163255A1 (fi)
CZ (1) CZ300895A3 (fi)
DE (2) DE4316537A1 (fi)
DK (1) DK0697867T3 (fi)
ES (1) ES2169073T3 (fi)
FI (1) FI955524A (fi)
HR (1) HRP940305A2 (fi)
HU (1) HUT73657A (fi)
IL (1) IL109532A (fi)
NO (1) NO954660D0 (fi)
NZ (1) NZ267080A (fi)
PL (1) PL311698A1 (fi)
SI (1) SI9420035A (fi)
WO (1) WO1994026267A1 (fi)
ZA (1) ZA943368B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
JP4997683B2 (ja) * 2000-09-25 2012-08-08 日本新薬株式会社 医薬固体分散体の製法
WO2003000226A2 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
DE60233874D1 (de) * 2001-06-22 2009-11-12 Pfizer Prod Inc Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
SK15732003A3 (sk) * 2001-06-22 2005-01-03 Pfizer Products Inc. Farmaceutické kompozície zahrnujúce liečivá s nízkou rozpustnosťou a/alebo liečivá citlivé na kyselinu a neutralizované kyslé polyméry
JPWO2003034302A1 (ja) * 2001-10-15 2005-02-03 株式会社シュタルク コンテンツ配信用サーバ及びこれを備えたコンテンツ配信システム
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
DE60322665D1 (de) 2002-02-01 2008-09-18 Pfizer Prod Inc Pharmazeutische darreichungsform mit gesteuerter freigabe eines cholesterylester-transferproteininhibitors
BR0313428A (pt) 2002-08-12 2005-06-28 Pfizer Prod Inc Composições farmacêuticas de drogas semi-ordenados e polìmeros
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
WO2005005401A1 (ja) * 2003-07-11 2005-01-20 Osaka Industrial Promotion Organization スルホン酸エステル化合物およびそれを用いた蛍光プローブ
EP1650200A4 (en) * 2003-07-11 2008-03-19 Osaka Ind Promotion Org SULPHONATE COMPOUND AND FLUORESCENCE ENCODER USING THIS
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS5446837A (en) * 1977-09-19 1979-04-13 Kanebo Ltd Easily absorbable nifedipin composition, its preparation, and anti-stenocardia containing the same
BE880713A (fr) * 1978-12-21 1980-06-19 Sandoz Sa Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
DE3243158A1 (de) * 1982-11-23 1984-05-24 Basf Ag, 6700 Ludwigshafen Neue sulfonsaeureester von hydroxycumarinen, ihre herstellung und sie enthaltende arzneimittel
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンa物質含有易溶性固形製剤
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
JP2636265B2 (ja) * 1987-10-06 1997-07-30 萬有製薬株式会社 脳循環改善剤
DE3830355A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur herstellung von pharmazeutischen tabletten
DE3834860A1 (de) * 1988-10-13 1990-04-19 Basf Ag Heterocyclisch substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel

Also Published As

Publication number Publication date
CZ300895A3 (en) 1996-02-14
HUT73657A (en) 1996-09-30
DE4316537A1 (de) 1994-11-24
HU9503296D0 (en) 1996-01-29
DE59409994D1 (de) 2002-01-17
NO954660L (no) 1995-11-17
CA2163255A1 (en) 1994-11-24
IL109532A0 (en) 1994-08-26
US5684040A (en) 1997-11-04
ATE209913T1 (de) 2001-12-15
NZ267080A (en) 1996-11-26
ES2169073T3 (es) 2002-07-01
AU6926394A (en) 1994-12-12
JPH08510219A (ja) 1996-10-29
SI9420035A (en) 1996-06-30
PL311698A1 (en) 1996-03-04
NO954660D0 (no) 1995-11-17
EP0697867A1 (de) 1996-02-28
IL109532A (en) 1997-11-20
AU688328B2 (en) 1998-03-12
DK0697867T3 (da) 2002-03-11
FI955524A0 (fi) 1995-11-16
EP0697867B1 (de) 2001-12-05
KR960702305A (ko) 1996-04-27
WO1994026267A1 (de) 1994-11-24
CN1123524A (zh) 1996-05-29
BR9406414A (pt) 1995-12-19
HRP940305A2 (en) 1996-12-31
ZA943368B (en) 1995-11-17

Similar Documents

Publication Publication Date Title
FI955524A (fi) Kiinteinä liuoksina olevia valmisteita
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
TR199801179T2 (xx) Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
KR910007538A (ko) α-아밀라아제 활성저해제
CA2326756A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients
MY104634A (en) 1-<[o-(cyclopropylcarbony)phenyl]>- 3-(4,6-dimethoxy-2-pyrimidinyl) urea and method for the preparation thereof.
FI852995L (fi) Stabila salter av polyanioner innehaollande s-adenosyl-l-methionin (sam).
CA2247848A1 (en) Nitric oxide donors capable of reducing toxicity from drugs
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
ES2101860T3 (es) Percarbonato de sodio encapsulado, estable al almacenamiento, y procedimiento para su preparacion.
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
GB8925833D0 (en) Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms
IT1224405B (it) Composti attivi sul sistema cardiovascolare
NO980058L (no) Opthalmiske preparater
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
IE870845L (en) N'-substituted-n,n'-diacylhydrazines
AU6878900A (en) 1,4-dihydropyridine-5-carboxylic acid ester derivatives and method for the preparation thereof
TR199800958A2 (xx) Herbisidal 3,5-Difloropridinleri.
GR970100096A (el) Εξωτερικη διαταξη κατα των παρασιτων για βοοειδη με βαση τη ν-φαινυλπυραζολη, ειδικα σκουλαρικια.
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
AU3138489A (en) Peptides with pharmaceutical activity
ATE252598T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
MY111499A (en) 1 - < [ - cyclopropyl - - (substituted oxy) - o - tolyl] sulfamoyl> -3- (4,6- dimethoxy - 2 - pyrimidinyl) urea herbicidal agents
KR950005303A (ko) 진균 감염 치료 방법(method of treating fungal infections)